The report will be delivered in 2-3 business days.

Ophthalmology Drugs Global Market Report 2021: COVID-19 Impact and Recovery to 2030

Starting Price : $5000 | Pages : 300 | Published : December 2020 | SKU CODE : r383 | Format :


The ophthalmology drugs market consists of sales of ophthalmology drugs and related services by entities (organizations, sole traders and partnerships) that produce ophthalmology drugs to treat eye related diseases. The ophthalmology drugs industry includes establishments that produce pharmaceutical drugs to treat glaucoma diseases, anti- inflammatory and tear stimulating drugs under dry eye medications drugs, and other drugs for treating retinal disorders and allergies. Some of the major ophthalmic drugs include Eylea, Lucentis, Restasis, Vigamox, Azopt, and Lotemax. The ophthalmology drugs market is segmented into antiglaucoma drugs; dry eye medication; and other ophthalmological drugs (retinal disorders, anti-infectives/allergy).

The global ophthalmology drugs market is expected to grow from $22.03 billion in 2020 to $24.42 billion in 2021 at a compound annual growth rate (CAGR) of 10.8%. The growth is mainly due to the companies rearranging their operations and recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The market is expected to reach $32.64 billion in 2025 at a CAGR of 8%.

North America was the largest region in the global ophthalmology drugs market, accounting for 41% of the market in 2020. Asia Pacific was the second largest region, accounting for 28% of the global ophthalmology drugs market. Africa was the smallest region in the global ophthalmology drugs market.

The expected rise in eye laser surgeries will contribute to the ophthalmology drugs market. Ophthalmology research has proved a link between laser eye surgeries and the prevalence of dry eye disorders. In an eye laser procedure, cutting of some nerves in the cornea leads to reduction in corneal sensitivity, in response to which, eyes may not sense the need for lubrication, causing the body to produce fewer tears. Dry eye is a common side effect after laser vision correction surgeries. It is estimated that almost half of the patients that undergo a laser surgery experience some degree of dry eye condition following the procedure. It is expected that the number of eye laser procedures will rise from 596,000 a year in 2015 to 720,000 a year in 2020. A rising number of people going for laser eye surgeries is expected to increase the demand for dry eye medications in the forecast period driving the ophthalmology drugs market.

Regulatory changes are likely to lead to increased costs relating to new product development and service offerings to clients. These changes are related to data protection such as the European Union's General Data Protection Regulation (GDPR), changes to drug approval procedures and other regulatory changes. For instance, according to a report by Ernst and Young in 2018, Fortune 500 companies are spending $7.8 billion to comply with GDPR regulations. The GDPR regulation is a EU law on data protection and privacy of individuals residing the European Union and the European Economic Area (EEA). It also regulates data anonymization thus maintaining integrity of data dealing with patients and other clinical trial studies. The potential loss of revenue due to delays in product release and additional costs incurred due to stringent approval processes puts strain to investments relating to new product development, thereby affecting the growth of the ophthalmology drugs market.

Drug manufacturers are increasingly developing ophthalmic drugs with anti-inflammatory agents to ease patient treatment for dry eye syndrome. Anti-inflammatory drugs are widely used for the treatment of the inflammation produced by the dry eye syndrome, with the topical corticosteroid drops being the most common therapy. Corticosteroids can rapidly and effectively relieve the symptoms and signs of moderate or severe dry eye. However, prolonged usage of corticosteroids has seen to produce side effects that include risk of bacterial or fungal infection, elevated intraocular pressure and cataract formation. As a consequence, NSAIDs are increasingly being used as dry eye treatment instead of steroids to minimize the side effects. For instance, Aciex Therapeutics, a US-based pharmaceutical company, is developing NSAIDs which decrease ocular discomfort.

The major players covered in the global ophthalmology drugs market are Novartis AG, F. Hoffmann-La Roche Ltd, Allergan Plc, Valeant Pharmaceuticals Intl Inc, Bayer AG.

The countries covered in the global ophthalmology drugs market are Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, China, Colombia, Czech Republic, Denmark, Egypt, Finland, France, Germany, Hong Kong, India, Indonesia, Ireland, Israel, Italy, Japan, Malaysia, Mexico, Netherlands, New Zealand, Nigeria, Norway, Peru, Philippines, Poland, Portugal, Romania, Russia, Saudi Arabia, Singapore, South Africa, South Korea, Spain, Sweden, Switzerland, Thailand, Turkey, UAE, UK, USA, Venezuela, Vietnam.

The regions covered in the global ophthalmology drugs market are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The global ophthalmology drugs market is segmented -

1) By Type: Antiglaucoma Drugs, Dry Eye Medication, Other Ophthalmological Drugs (Retinal Disorders, Anti-Infectives/Allergy)

2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies/ Drug Stores, Others

3) By Route Of Administration: Oral, Parenteral, Others

4) By Drug Classification: Branded Drugs, Generic Drugs

5) By Mode Of Purchase: Prescription-Based Drugs, Over-The-Counter Drugs

    1. Executive Summary

    2. Report Structure

    3. Ophthalmology Drugs Market Characteristics

    3.1. Market Definition

    3.2. Key Segmentations

    4. Ophthalmology Drugs Market Product Analysis

    4.1. Leading Products/ Services

    4.2. Key Features and Differentiators

    4.3. Development Products

    5. Ophthalmology Drugs Market Supply Chain

    5.1. Supply Chain

    5.2. Distribution

    5.3. End Customers

    6. Ophthalmology Drugs Market Customer Information

    6.1. Customer Preferences

    6.2. End Use Market Size and Growth

    7. Ophthalmology Drugs Market Trends And Strategies

    8. Impact Of COVID-19 On Ophthalmology Drugs

    9. Ophthalmology Drugs Market Size And Growth

    9.1. Market Size

    9.2. Historic Market Growth, Value ($ Billion)

    9.2.1. Drivers Of The Market

    9.2.2. Restraints On The Market

    9.3. Forecast Market Growth, Value ($ Billion)

    9.3.1. Drivers Of The Market

    9.3.2. Restraints On The Market

    10. Ophthalmology Drugs Market Regional Analysis

    10.1. Global Ophthalmology Drugs Market, 2020, By Region, Value ($ Billion)

    10.2. Global Ophthalmology Drugs Market, 2015-2020, 2020-2025F, 2030F, Historic And Forecast, By Region

    10.3. Global Ophthalmology Drugs Market, Growth And Market Share Comparison, By Region

    11. Ophthalmology Drugs Market Segmentation

    11.1. Global Ophthalmology Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    Antiglaucoma Drugs

    Dry Eye Medication

    Other Ophthalmological Drugs (Retinal Disorders, Anti-Infectives/Allergy)

    11.2. Global Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    Hospital Pharmacies

    Retail Pharmacies/ Drug Stores

    Others

    11.3. Global Ophthalmology Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    Oral

    Parenteral

    Others

    11.4. Global Ophthalmology Drugs Market, Segmentation By Drug Classification, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    Branded Drugs

    Generic Drugs

    11.5. Global Ophthalmology Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    Prescription-Based Drugs

    Over-The-Counter Drugs

    12. Ophthalmology Drugs Market Metrics

    12.1. Ophthalmology Drugs Market Size, Percentage Of GDP, 2015-2025, Global

    12.2. Per Capita Average Ophthalmology Drugs Market Expenditure, 2015-2025, Global

    13. Asia-Pacific Ophthalmology Drugs Market

    13.1. Asia-Pacific Ophthalmology Drugs Market Overview

    Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    13.2. Asia-Pacific, Ophthalmology Drugs Market, 2020, By Country, Value ($ Billion)

    13.3. Asia-Pacific, Ophthalmology Drugs Market, 2015-2020, 2020-2025F, 2030F, Historic And Forecast, By Country

    13.4. Asia-Pacific, Ophthalmology Drugs Market, 2015-2020, 2020-2025F, 2030F, Growth And Market Share Comparison, By Country

    13.5. Asia-Pacific, Ophthalmology Drugs Market Metrics

    13.5.1. Per Capita Average Ophthalmology Drugs Expenditure, 2015-2025, Asia-Pacific Countries

    13.6. Asia-Pacific Ophthalmology Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    13.7. Asia-Pacific Ophthalmology Drugs Market: Country Analysis

    13.7.1. China Ophthalmology Drugs Market

    13.7.1.1. China Ophthalmology Drugs Market Overview

    13.7.1.2. China Ophthalmology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    13.7.1.3. China Ophthalmology Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    13.7.2. Australia Ophthalmology Drugs Market

    13.7.2.1. Australia Ophthalmology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    13.7.2.2. Australia Ophthalmology Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    13.7.3. Hong Kong Ophthalmology Drugs Market

    13.7.3.1. Hong Kong Ophthalmology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    13.7.4. India Ophthalmology Drugs Market

    13.7.4.1. India Ophthalmology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    13.7.4.2. India Ophthalmology Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    13.7.5. Indonesia Ophthalmology Drugs Market

    13.7.5.1. Indonesia Ophthalmology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    13.7.5.2. Indonesia Ophthalmology Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    13.7.6. Japan Ophthalmology Drugs Market

    13.7.6.1. Japan Ophthalmology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    13.7.6.2. Japan Ophthalmology Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    13.7.7. Malaysia Ophthalmology Drugs Market

    13.7.7.1. Malaysia Ophthalmology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    13.7.8. New Zealand Ophthalmology Drugs Market

    13.7.8.1. New Zealand Ophthalmology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    13.7.9. Philippines Ophthalmology Drugs Market

    13.7.9.1. Philippines Ophthalmology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    13.7.10. Singapore Ophthalmology Drugs Market

    13.7.10.1. Singapore Ophthalmology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    13.7.11. South Korea Ophthalmology Drugs Market

    13.7.11.1. South Korea Ophthalmology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    13.7.11.2. South Korea Ophthalmology Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    13.7.12. Thailand Ophthalmology Drugs Market

    13.7.12.1. Thailand Ophthalmology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    13.7.13. Vietnam Ophthalmology Drugs Market

    13.7.13.1. Vietnam Ophthalmology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    14. Western Europe Ophthalmology Drugs Market

    14.1. Western Europe Ophthalmology Drugs Market Overview

    14.2. Western Europe, Ophthalmology Drugs Market, 2020, By Country, Value ($ Billion)

    14.3. Western Europe, Ophthalmology Drugs Market, 2015-2020, 2020-2025F, 2030F, Historic And Forecast, By Country

    14.4. Western Europe, Ophthalmology Drugs Market, 2015-2020, 2020-2025F, 2030F, Growth And Market Share Comparison, By Country

    14.5. Western Europe, Ophthalmology Drugs Market Metrics

    14.5.1. Per Capita Average Ophthalmology Drugs Expenditure, 2015-2025, Western Europe Countries

    14.6. Western Europe Ophthalmology Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    14.7. Western Europe Ophthalmology Drugs Market: Country Analysis

    14.7.1. Austria Ophthalmology Drugs Market

    14.7.1.1. Austria Ophthalmology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    14.7.2. Belgium Ophthalmology Drugs Market

    14.7.2.1. Belgium Ophthalmology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    14.7.3. Denmark Ophthalmology Drugs Market

    14.7.3.1. Denmark Ophthalmology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    14.7.4. Finland Ophthalmology Drugs Market

    14.7.4.1. Finland Ophthalmology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    14.7.5. France Ophthalmology Drugs Market

    14.7.5.1. France Ophthalmology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    14.7.5.2. France Ophthalmology Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    14.7.6. Germany Ophthalmology Drugs Market

    14.7.6.1. Germany Ophthalmology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    14.7.6.2. Germany Ophthalmology Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    14.7.7. Ireland Ophthalmology Drugs Market

    14.7.7.1. Ireland Ophthalmology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    14.7.8. Italy Ophthalmology Drugs Market

    14.7.8.1. Italy Ophthalmology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    14.7.9. Netherlands Ophthalmology Drugs Market

    14.7.9.1. Netherlands Ophthalmology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    14.7.10. Norway Ophthalmology Drugs Market

    14.7.10.1. Norway Ophthalmology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    14.7.11. Portugal Ophthalmology Drugs Market

    14.7.11.1. Portugal Ophthalmology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    14.7.12. Spain Ophthalmology Drugs Market

    14.7.12.1. Spain Ophthalmology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    14.7.13. Sweden Ophthalmology Drugs Market

    14.7.13.1. Sweden Ophthalmology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    14.7.14. Switzerland Ophthalmology Drugs Market

    14.7.14.1. Switzerland Ophthalmology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    14.7.15. UK Ophthalmology Drugs Market

    14.7.15.1. UK Ophthalmology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    14.7.15.2. UK Ophthalmology Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    15. Eastern Europe Ophthalmology Drugs Market

    15.1. Eastern Europe Ophthalmology Drugs Market Overview

    15.2. Eastern Europe, Ophthalmology Drugs Market, 2020, By Country, Value ($ Billion)

    15.3. Eastern Europe, Ophthalmology Drugs Market, 2015-2020, 2020-2025F, 2030F, Historic And Forecast, By Country

    15.4. Eastern Europe, Ophthalmology Drugs Market, 2015-2020, 2020-2025F, 2030F, Growth And Market Share Comparison, By Country

    15.5. Eastern Europe, Ophthalmology Drugs Market Metrics

    15.5.1. Per Capita Average Ophthalmology Drugs Expenditure, 2015-2025, Eastern Europe Countries

    15.6. Eastern Europe Ophthalmology Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    15.7. Eastern Europe Ophthalmology Drugs Market: Country Analysis

    15.7.1. Czech Republic Ophthalmology Drugs Market,  

    15.7.1.1. Czech Republic Ophthalmology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    15.7.2. Poland Ophthalmology Drugs Market

    15.7.2.1. Poland Ophthalmology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    15.7.3. Romania Ophthalmology Drugs Market

    15.7.3.1. Romania Ophthalmology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    15.7.4. Russia Ophthalmology Drugs Market

    15.7.4.1. Russia Ophthalmology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    15.7.4.2. Russia Ophthalmology Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    16. North America Ophthalmology Drugs Market

    16.1. North America Ophthalmology Drugs Market Overview

    16.2. North America, Ophthalmology Drugs Market, 2020, By Country, Value ($ Billion)

    16.3. North America, Ophthalmology Drugs Market, 2015-2020, 2020-2025F, 2030F, Historic And Forecast, By Country

    16.4. North America, Ophthalmology Drugs Market, 2015-2020, 2020-2025F, 2030F, Growth And Market Share Comparison, By Country

    16.5. North America, Ophthalmology Drugs Market Metrics

    16.5.1. Per Capita Average Ophthalmology Drugs Expenditure, 2015-2025, North America Countries

    16.6. North America Ophthalmology Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    16.7. North America Ophthalmology Drugs Market: Country Analysis

    16.7.1. Canada Ophthalmology Drugs Market

    16.7.1.1. Canada Ophthalmology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    16.7.2. Mexico Ophthalmology Drugs Market

    16.7.2.1. Mexico Ophthalmology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    16.7.3. USA Ophthalmology Drugs Market

    16.7.3.1. USA Ophthalmology Drugs Market Overview

    16.7.3.2. USA Ophthalmology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    16.7.3.3. USA Ophthalmology Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    17. South America Ophthalmology Drugs Market

    17.1. South America Ophthalmology Drugs Market Overview

    17.2. South America, Ophthalmology Drugs Market, 2020, By Country, Value ($ Billion)

    17.3. South America, Ophthalmology Drugs Market, 2015-2020, 2020-2025F, 2030F, Historic And Forecast, By Country

    17.4. South America, Ophthalmology Drugs Market, 2015-2020, 2020-2025F, 2030F, Growth And Market Share Comparison, By Country

    17.5. South America, Ophthalmology Drugs Market Metrics

    17.5.1. Per Capita Average Ophthalmology Drugs Expenditure, 2015-2025, South America Countries

    17.6. South America Ophthalmology Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    17.7. South America Ophthalmology Drugs Market: Country Analysis

    17.7.1. Argentina Ophthalmology Drugs Market

    17.7.1.1. Argentina Ophthalmology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    17.7.2. Brazil Ophthalmology Drugs Market

    17.7.1.1. Brazil Ophthalmology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    17.7.2.2. Brazil Ophthalmology Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    17.7.3. Chile Ophthalmology Drugs Market

    17.7.3.1. Chile Ophthalmology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    17.7.4. Colombia Ophthalmology Drugs Market

    17.7.4.1. Colombia Ophthalmology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    17.7.5. Peru Ophthalmology Drugs Market

    17.7.5.1. Peru Ophthalmology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    17.7.6. Venezuela Ophthalmology Drugs Market

    17.7.6.1. Venezuela Ophthalmology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    18. Middle East Ophthalmology Drugs Market

    18.1. Middle East Ophthalmology Drugs Market Overview

    18.2. Middle East, Ophthalmology Drugs Market, 2020, By Country, Value ($ Billion)

    18.3. Middle East, Ophthalmology Drugs Market, 2015-2020, 2020-2025F, 2030F, Historic And Forecast, By Country

    18.4. Middle East, Ophthalmology Drugs Market, 2015-2020, 2020-2025F, 2030F, Growth And Market Share Comparison, By Country

    18.5. Middle East, Ophthalmology Drugs Market Metrics

    18.5.1. Per Capita Average Ophthalmology Drugs Expenditure, 2015-2025, Middle East Countries

    18.6. Middle East Ophthalmology Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    18.7. Middle East Ophthalmology Drugs Market: Country Analysis

    18.7.1. Saudi Arabia Ophthalmology Drugs Market

    18.7.1.1. Saudi Arabia Ophthalmology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    18.7.2. Israel Ophthalmology Drugs Market

    18.7.2.1. Israel Ophthalmology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    18.7.3. Turkey Ophthalmology Drugs Market

    18.7.3.1. Turkey Ophthalmology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    18.7.4. UAE Ophthalmology Drugs Market

    18.7.4.1. UAE Ophthalmology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    19. Africa Ophthalmology Drugs Market

    19.1. Africa Ophthalmology Drugs Market Overview

    19.2. Africa, Ophthalmology Drugs Market, 2020, By Country, Value ($ Billion)

    19.3. Africa, Ophthalmology Drugs Market, 2015-2020, 2020-2025F, 2030F, Historic And Forecast, By Country

    19.4. Africa, Ophthalmology Drugs Market, 2015-2020, 2020-2025F, 2030F, Growth And Market Share Comparison, By Country

    19.5. Africa, Ophthalmology Drugs Market Metrics

    19.5.1. Per Capita Average Ophthalmology Drugs Expenditure, 2015-2025, Africa Countries

    19.6. Africa Ophthalmology Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    19.7. Africa Ophthalmology Drugs Market: Country Analysis

    19.7.1. Egypt Ophthalmology Drugs Market

    19.7.1.1. Egypt Ophthalmology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    19.7.2. Nigeria Ophthalmology Drugs Market

    19.7.2.1. Nigeria Ophthalmology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    19.7.3. South Africa Ophthalmology Drugs Market

    19.7.3.1. South Africa Ophthalmology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

    20. Ophthalmology Drugs Market Competitive Landscape

    20.1. Competitive Market Overview

    20.2. Market Shares

    20.3. Company Profiles

    20.3.1. Novartis AG

    20.3.1.1. Company Overview

    20.3.1.2. Products And Services

    20.3.1.3. Strategy

    20.3.1.4. Financial Performance

    20.3.2. F. Hoffmann-La Roche Ltd

    20.3.2.1. Company Overview

    20.3.2.2. Products And Services

    20.3.2.3. Strategy

    20.3.2.4. Financial Performance

    20.3.3. Allergan Plc

    20.3.3.1. Company Overview

    20.3.3.2. Products And Services

    20.3.3.3. Strategy

    20.3.3.4. Financial Performance

    20.3.4. Valeant Pharmaceuticals Intl Inc

    20.3.4.1. Company Overview

    20.3.4.2. Products And Services

    20.3.4.3. Strategy

    20.3.4.4. Financial Performance

    20.3.5. Bayer AG

    20.3.5.1. Company Overview

    20.3.5.2. Products And Services

    20.3.5.3. Strategy

    20.3.5.4. Financial Performance

    21. Key Mergers And Acquisitions In The Ophthalmology Drugs Market

    22. Market Background: Pharmaceutical Drugs Market

    22.1. Pharmaceutical Drugs Market Characteristics

    22.2. Pharmaceutical Drugs Market Historic and Forecast, 2015-2020, 2020-2025F, 2030F Growth, By Segment, Value ($ Billion), Global

    22.3. Global Pharmaceutical Drugs Market, 2020, By Region, Value ($ Billion)

    22.4. Global Pharmaceutical Drugs Market, 2015-2020, 2020-2025F, 2030F, Historic And Forecast, By Region

    22.5. Global Pharmaceutical Drugs Market, 2015-2020, 2020-2025F, 2030F, Segmentation By Type, Value ($ Billion)

    23. Recommendations

    23.1. Global Ophthalmology Drugs Market In 2025- Growth Countries

    23.2. Global Ophthalmology Drugs Market In 2025- Growth Segments

    23.3. Global Ophthalmology Drugs Market In 2025- Growth Strategies

    24. Appendix

    24.1. NAICS Definitions Of Industry Covered In This Report

    24.2. Abbreviations

    24.3. Currencies

    24.4. Research Inquiries

    24.5. The Business Research Company

    25. Copyright And Disclaimer

List Of Tables

    Table 1: Historic Market Growth, Value ($ Billion)
  • Table 2: Forecast Market Growth, Value ($ Billion)
  • Table 3: Global Ophthalmology Drugs Market, 2020, By Region, Value ($ Billion)
  • Table 4: Global Ophthalmology Drugs Market, 2015-2020, 2020-2025F, 2030F, Historic And Forecast, By Region
  • Table 5: Global Ophthalmology Drugs Market, Growth And Market Share Comparison, By Region
  • Table 6: Global Ophthalmology Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 7: Global Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 8: Global Ophthalmology Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 9: Global Ophthalmology Drugs Market, Segmentation By Drug Classification, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 10: Global Ophthalmology Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 11: Ophthalmology Drugs Market Size, Percentage Of GDP, 2015-2025, Global
  • Table 12: Per Capita Average Ophthalmology Drugs Market Expenditure, 2015-2025, Global
  • Table 13: Asia-Pacific, Ophthalmology Drugs Market, 2020, By Country, Value ($ Billion)
  • Table 14: Asia-Pacific, Ophthalmology Drugs Market, 2015-2020, 2020-2025F, 2030F, Historic And Forecast, By Country
  • Table 15: Asia-Pacific, Ophthalmology Drugs Market, 2015-2020, 2020-2025F, 2030F, Growth And Market Share Comparison, By Country
  • Table 16: Per Capita Average Ophthalmology Drugs Expenditure, 2015-2025, Asia-Pacific Countries
  • Table 17: Asia-Pacific Ophthalmology Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 18: China Ophthalmology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 19: China Ophthalmology Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 20: Australia Ophthalmology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 21: Australia Ophthalmology Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 22: Hong Kong Ophthalmology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 23: India Ophthalmology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 24: India Ophthalmology Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 25: Indonesia Ophthalmology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 26: Indonesia Ophthalmology Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 27: Japan Ophthalmology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 28: Japan Ophthalmology Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 29: Malaysia Ophthalmology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 30: New Zealand Ophthalmology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 31: Philippines Ophthalmology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 32: Singapore Ophthalmology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 33: South Korea Ophthalmology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 34: Thailand Ophthalmology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 35: Vietnam Ophthalmology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 36: Western Europe, Ophthalmology Drugs Market, 2020, By Country, Value ($ Billion)
  • Table 37: Western Europe, Ophthalmology Drugs Market, 2015-2020, 2020-2025F, 2030F, Historic And Forecast, By Country
  • Table 38: Western Europe, Ophthalmology Drugs Market, 2015-2020, 2020-2025F, 2030F, Growth And Market Share Comparison, By Country
  • Table 39: Per Capita Average Ophthalmology Drugs Expenditure, 2015-2025, Western Europe Countries
  • Table 40: Western Europe Ophthalmology Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 41: Austria Ophthalmology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 42: Belgium Ophthalmology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 43: Denmark Ophthalmology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 44: Finland Ophthalmology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 45: France Ophthalmology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 46: France Ophthalmology Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 47: Germany Ophthalmology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 48: Germany Ophthalmology Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 49: Ireland Ophthalmology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 50: Italy Ophthalmology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 51: Netherlands Ophthalmology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 52: Norway Ophthalmology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 53: Portugal Ophthalmology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 54: Spain Ophthalmology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 55: Sweden Ophthalmology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 56: Switzerland Ophthalmology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 57: UK Ophthalmology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 58: UK Ophthalmology Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 59: Eastern Europe, Ophthalmology Drugs Market, 2020, By Country, Value ($ Billion)
  • Table 60: Eastern Europe, Ophthalmology Drugs Market, 2015-2020, 2020-2025F, 2030F, Historic And Forecast, By Country
  • Table 61: Eastern Europe, Ophthalmology Drugs Market, 2015-2020, 2020-2025F, 2030F, Growth And Market Share Comparison, By Country
  • Table 62: Per Capita Average Ophthalmology Drugs Expenditure, 2015-2025, Eastern Europe Countries
  • Table 63: Eastern Europe Ophthalmology Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 64: Czech Republic Ophthalmology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 65: Poland Ophthalmology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 66: Romania Ophthalmology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 67: Russia Ophthalmology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 68: Russia Ophthalmology Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 69: North America, Ophthalmology Drugs Market, 2020, By Country, Value ($ Billion)
  • Table 70: North America, Ophthalmology Drugs Market, 2015-2020, 2020-2025F, 2030F, Historic And Forecast, By Country
  • Table 71: North America, Ophthalmology Drugs Market, 2015-2020, 2020-2025F, 2030F, Growth And Market Share Comparison, By Country
  • Table 72: Per Capita Average Ophthalmology Drugs Expenditure, 2015-2025, North America Countries
  • Table 73: North America Ophthalmology Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 74: Canada Ophthalmology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 75: Mexico Ophthalmology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 76: USA Ophthalmology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 77: USA Ophthalmology Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 78: South America, Ophthalmology Drugs Market, 2020, By Country, Value ($ Billion)
  • Table 79: South America, Ophthalmology Drugs Market, 2015-2020, 2020-2025F, 2030F, Historic And Forecast, By Country
  • Table 80: South America, Ophthalmology Drugs Market, 2015-2020, 2020-2025F, 2030F, Growth And Market Share Comparison, By Country
  • Table 81: Per Capita Average Ophthalmology Drugs Expenditure, 2015-2025, South America Countries
  • Table 82: South America Ophthalmology Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 83: Argentina Ophthalmology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 84: Brazil Ophthalmology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 85: Brazil Ophthalmology Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 86: Chile Ophthalmology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 87: Colombia Ophthalmology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 88: Peru Ophthalmology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 89: Venezuela Ophthalmology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 90: Middle East, Ophthalmology Drugs Market, 2020, By Country, Value ($ Billion)
  • Table 91: Middle East, Ophthalmology Drugs Market, 2015-2020, 2020-2025F, 2030F, Historic And Forecast, By Country
  • Table 92: Middle East, Ophthalmology Drugs Market, 2015-2020, 2020-2025F, 2030F, Growth And Market Share Comparison, By Country
  • Table 93: Per Capita Average Ophthalmology Drugs Expenditure, 2015-2025, Middle East Countries
  • Table 94: Middle East Ophthalmology Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 95: Saudi Arabia Ophthalmology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 96: Israel Ophthalmology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 97: Turkey Ophthalmology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 98: UAE Ophthalmology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 99: Africa, Ophthalmology Drugs Market, 2020, By Country, Value ($ Billion)
  • Table 100: Africa, Ophthalmology Drugs Market, 2015-2020, 2020-2025F, 2030F, Historic And Forecast, By Country
  • Table 101: Africa, Ophthalmology Drugs Market, 2015-2020, 2020-2025F, 2030F, Growth And Market Share Comparison, By Country
  • Table 102: Per Capita Average Ophthalmology Drugs Expenditure, 2015-2025, Africa Countries
  • Table 103: Africa Ophthalmology Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 104: Egypt Ophthalmology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 105: Nigeria Ophthalmology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 106: South Africa Ophthalmology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Table 107: Novartis AG Financial Performance
  • Table 108: F. Hoffmann-La Roche Ltd Financial Performance
  • Table 109: Allergan Plc Financial Performance
  • Table 110: Valeant Pharmaceuticals Intl Inc Financial Performance
  • Table 111: Bayer AG Financial Performance
  • Table 112: Pharmaceutical Drugs Market Historic and Forecast, 2015-2020, 2020-2025F, 2030F, Growth, By Segment, Value ($ Billion), Global
  • Table 113: Global Pharmaceutical Drugs Market, 2020, By Region, Value ($ Billion)
  • Table 114: Global Pharmaceutical Drugs Market, 2015-2020, 2020-2025F, 2030F, Historic And Forecast, By Region
  • Table 115: Global Pharmaceutical Drugs Market, 2015-2020, 2020-2025F, 2030F, Segmentation By Type, Value ($ Billion)
  • Table 116: Global Ophthalmology Drugs Market In 2025- Growth Countries
  • Table 117: Global Ophthalmology Drugs Market In 2025- Growth Segments
  • Table 118: Global Ophthalmology Drugs Market In 2025- Growth Strategies

List Of Figures

    Figure 1: Historic Market Growth, Value ($ Billion)
  • Figure 2: Forecast Market Growth, Value ($ Billion)
  • Figure 3: Global Ophthalmology Drugs Market, 2020, By Region, Value ($ Billion)
  • Figure 4: Global Ophthalmology Drugs Market, 2015-2020, 2020-2025F, 2030F, Historic And Forecast, By Region
  • Figure 5: Global Ophthalmology Drugs Market, Growth And Market Share Comparison, By Region
  • Figure 6: Global Ophthalmology Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 7: Global Ophthalmology Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 8: Global Ophthalmology Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 9: Global Ophthalmology Drugs Market, Segmentation By Drug Classification, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 10: Global Ophthalmology Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 11: Ophthalmology Drugs Market Size, Percentage Of GDP, 2015-2025, Global
  • Figure 12: Per Capita Average Ophthalmology Drugs Market Expenditure, 2015-2025, Global
  • Figure 13: Asia-Pacific, Ophthalmology Drugs Market, 2020, By Country, Value ($ Billion)
  • Figure 14: Asia-Pacific, Ophthalmology Drugs Market, 2015-2020, 2020-2025F, 2030F, Historic And Forecast, By Country
  • Figure 15: Asia-Pacific, Ophthalmology Drugs Market, 2015-2020, 2020-2025F, 2030F, Growth And Market Share Comparison, By Country
  • Figure 16: Per Capita Average Ophthalmology Drugs Expenditure, 2015-2025, Asia-Pacific Countries
  • Figure 17: Asia-Pacific Ophthalmology Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 18: China Ophthalmology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 19: China Ophthalmology Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 20: Australia Ophthalmology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 21: Australia Ophthalmology Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 22: Hong Kong Ophthalmology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 23: India Ophthalmology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 24: India Ophthalmology Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 25: Indonesia Ophthalmology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 26: Indonesia Ophthalmology Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 27: Japan Ophthalmology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 28: Japan Ophthalmology Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 29: Malaysia Ophthalmology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 30: New Zealand Ophthalmology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 31: Philippines Ophthalmology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 32: Singapore Ophthalmology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 33: South Korea Ophthalmology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 34: Thailand Ophthalmology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 35: Vietnam Ophthalmology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 36: Western Europe, Ophthalmology Drugs Market, 2020, By Country, Value ($ Billion)
  • Figure 37: Western Europe, Ophthalmology Drugs Market, 2015-2020, 2020-2025F, 2030F, Historic And Forecast, By Country
  • Figure 38: Western Europe, Ophthalmology Drugs Market, 2015-2020, 2020-2025F, 2030F, Growth And Market Share Comparison, By Country
  • Figure 39: Per Capita Average Ophthalmology Drugs Expenditure, 2015-2025, Western Europe Countries
  • Figure 40: Western Europe Ophthalmology Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 41: Austria Ophthalmology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 42: Belgium Ophthalmology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 43: Denmark Ophthalmology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 44: Finland Ophthalmology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 45: France Ophthalmology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 46: France Ophthalmology Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 47: Germany Ophthalmology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 48: Germany Ophthalmology Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 49: Ireland Ophthalmology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 50: Italy Ophthalmology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 51: Netherlands Ophthalmology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 52: Norway Ophthalmology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 53: Portugal Ophthalmology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 54: Spain Ophthalmology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 55: Sweden Ophthalmology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 56: Switzerland Ophthalmology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 57: UK Ophthalmology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 58: UK Ophthalmology Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 59: Eastern Europe, Ophthalmology Drugs Market, 2020, By Country, Value ($ Billion)
  • Figure 60: Eastern Europe, Ophthalmology Drugs Market, 2015-2020, 2020-2025F, 2030F, Historic And Forecast, By Country
  • Figure 61: Eastern Europe, Ophthalmology Drugs Market, 2015-2020, 2020-2025F, 2030F, Growth And Market Share Comparison, By Country
  • Figure 62: Per Capita Average Ophthalmology Drugs Expenditure, 2015-2025, Eastern Europe Countries
  • Figure 63: Eastern Europe Ophthalmology Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 64: Czech Republic Ophthalmology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 65: Poland Ophthalmology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 66: Romania Ophthalmology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 67: Russia Ophthalmology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 68: Russia Ophthalmology Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 69: North America, Ophthalmology Drugs Market, 2020, By Country, Value ($ Billion)
  • Figure 70: North America, Ophthalmology Drugs Market, 2015-2020, 2020-2025F, 2030F, Historic And Forecast, By Country
  • Figure 71: North America, Ophthalmology Drugs Market, 2015-2020, 2020-2025F, 2030F, Growth And Market Share Comparison, By Country
  • Figure 72: Per Capita Average Ophthalmology Drugs Expenditure, 2015-2025, North America Countries
  • Figure 73: North America Ophthalmology Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 74: Canada Ophthalmology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 75: Mexico Ophthalmology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 76: USA Ophthalmology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 77: USA Ophthalmology Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 78: South America, Ophthalmology Drugs Market, 2020, By Country, Value ($ Billion)
  • Figure 79: South America, Ophthalmology Drugs Market, 2015-2020, 2020-2025F, 2030F, Historic And Forecast, By Country
  • Figure 80: South America, Ophthalmology Drugs Market, 2015-2020, 2020-2025F, 2030F, Growth And Market Share Comparison, By Country
  • Figure 81: Per Capita Average Ophthalmology Drugs Expenditure, 2015-2025, South America Countries
  • Figure 82: South America Ophthalmology Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 83: Argentina Ophthalmology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 84: Brazil Ophthalmology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 85: Brazil Ophthalmology Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 86: Chile Ophthalmology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 87: Colombia Ophthalmology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 88: Peru Ophthalmology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 89: Venezuela Ophthalmology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 90: Middle East, Ophthalmology Drugs Market, 2020, By Country, Value ($ Billion)
  • Figure 91: Middle East, Ophthalmology Drugs Market, 2015-2020, 2020-2025F, 2030F, Historic And Forecast, By Country
  • Figure 92: Middle East, Ophthalmology Drugs Market, 2015-2020, 2020-2025F, 2030F, Growth And Market Share Comparison, By Country
  • Figure 93: Per Capita Average Ophthalmology Drugs Expenditure, 2015-2025, Middle East Countries
  • Figure 94: Middle East Ophthalmology Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 95: Saudi Arabia Ophthalmology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 96: Israel Ophthalmology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 97: Turkey Ophthalmology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 98: UAE Ophthalmology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 99: Africa, Ophthalmology Drugs Market, 2020, By Country, Value ($ Billion)
  • Figure 100: Africa, Ophthalmology Drugs Market, 2015-2020, 2020-2025F, 2030F, Historic And Forecast, By Country
  • Figure 101: Africa, Ophthalmology Drugs Market, 2015-2020, 2020-2025F, 2030F, Growth And Market Share Comparison, By Country
  • Figure 102: Per Capita Average Ophthalmology Drugs Expenditure, 2015-2025, Africa Countries
  • Figure 103: Africa Ophthalmology Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 104: Egypt Ophthalmology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 105: Nigeria Ophthalmology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 106: South Africa Ophthalmology Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • Figure 107: Novartis AG Financial Performance
  • Figure 108: F. Hoffmann-La Roche Ltd Financial Performance
  • Figure 109: Allergan Plc Financial Performance
  • Figure 110: Valeant Pharmaceuticals Intl Inc Financial Performance
  • Figure 111: Bayer AG Financial Performance
  • Figure 112: Pharmaceutical Drugs Market Historic and Forecast, 2015-2020, 2020-2025F, 2030F, Growth, By Segment, Value ($ Billion), Global
  • Figure 113: Global Pharmaceutical Drugs Market, 2020, By Region, Value ($ Billion)
  • Figure 114: Global Pharmaceutical Drugs Market, 2015-2020, 2020-2025F, 2030F, Historic And Forecast, By Region
  • Figure 115: Global Pharmaceutical Drugs Market, 2015-2020, 2020-2025F, 2030F, Segmentation By Type, Value ($ Billion)
  • Figure 116: Global Ophthalmology Drugs Market In 2025- Growth Countries
  • Figure 117: Global Ophthalmology Drugs Market In 2025- Growth Segments
  • Figure 118: Global Ophthalmology Drugs Market In 2025- Growth Strategies
Global Lung Cancer Drugs Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Global Kidney Cancer Drugs Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Global Interleukin Inhibitors Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Global Immunosuppressants Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Global Inhalation Sedatives Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Global Insulin Drugs Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Global Cancer Monoclonal Antibodies Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Global Clinical Nutrition Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Oncology Drugs Market - By Type (Blood Cancer, Breast Cancer, Lung Cancer, Prostate cancer, Colorectal Cancer, Cervical cancer, Kidney cancer, Gastric Cancer, Brain Tumor, Skin Cancer, Ovarian Cancer, Bladder Cancer, Pancreatic Cancer, Thyroid cancer, Others), By Drug Class Type (Targeted Therapy, Immunotherapy (Biologic Therapy), Chemotherapy, Hormonal Therapy), By Distribution Channel (Retail Pharmacies/Drug Stores, Hospital Pharmacies, Others), By Route Of Administration (Oral, Parenteral, Others), By Drug Classification (Branded, Generic), And By Region, Opportunities And Strategies - Global Forecast To 2030
View Report
CAR-T Therapy Market - By Target Antigen (CD19 Therapy, CD22 Therapy, BCMA Therapy, Others), By Application (Acute Lymphoblastic Leukemia, Diffuse Large B-Cell Lymphoma, Follicular Lymphoma, Chronic Lymphocytic Leukemia, Multiple Myeloma, Others), And By Region, Opportunities And Strategies - Global Forecast To 2030
View Report
Dry Eye Medication Market - By Prescription Type (OTC Drugs, Prescription Drugs) By Drug Variation (Branded, Generic) By Type Of Product (Aqueous, Evaporative, Aqueous and Evaporative) By Distribution Channel (Hospital Pharmacies, Eye Health Clinics, Retail Pharmacies, Online Pharmacies) By Delivery System (Liquid, Gel, Ointment, Others) And By Region, Opportunities And Strategies – Global Forecast To 2030
View Report
Ophthalmology Drugs Market - By Type (Antglaucoma Drugs, Dry Eye Medication And Other Ophthalmological Drugs), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies/ Drug Stores And Others), By Drug Classification (Branded Drugs And Generic Drugs), By Mode Of Purchase (Prescription-Based Drugs, Over-The-Counter Drugs) And, By Region, Opportunities And Strategies – Global Forecast To 2030
View Report
Pharmaceutical Drugs Market - By Segments (Musculoskeletal Disorders Drugs, Cardiovascular Drugs, Oncology Drugs, Anti-Infective Drugs, Metabolic Disorder Drugs, Central Nervous System Drugs, Genito-Urinary Drugs, Respiratory Diseases Drugs, Gastrointestinal Drugs, Hematology Drugs, Dermatology Drugs, Ophthalmology Drugs), And By Region, Opportunities And Strategies – Global Forecast To 2030
View Report
Musculoskeletal Drugs Market Global Briefing 2018
View Report
Respiratory Drugs Market Global Briefing 2018
View Report
Antisense And RNAi Therapeutics Market- By Technology (RNA Interference, Antisense RNA), By Route Of Administration (Intravenous injections, Intra Dermal injunctions, Other delivery methods), By Indication (Oncology, Cardiovascular device, Respiratory disorders, Neurological disorders, Infectious disease, Other diseases), And By Region, Opportunities And Strategies – Global Forecast To 2030
View Report

Call Us

+1 3156230293

(Americas)

+44 2071930708

(Europe)

+91 8897263534

(Asia & Others)